Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.

Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.

Item
http://www.wikidata.org/entity/Q33962846
Development of real-time PCR array for simultaneous detection of eight human blood-borne viral pathogens.The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets.Antiviral drug resistance and the need for development of new HIV-1 reverse transcriptase inhibitors.Investigational reverse transcriptase inhibitors for the treatment of HIV.Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors.The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug ResistanceEvaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.Update on tenofovir toxicity in the kidney.The acyclic nucleoside phosphonates (ANPs): Antonín Holý's legacy.Proteins, peptides, polysaccharides, and nucleotides with inhibitory activity on human immunodeficiency virus and its enzymes.Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsidCommonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide.Structure-activity relationships of a novel capsid targeted inhibitor of HIV-1 replication.Tenofovir nephrotoxicity: 2011 update.Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs.
P2860

Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.

Item
http://www.wikidata.org/entity/Q33962846
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development of hexadecyloxypro ...... side/nucleotide-resistant HIV.
@ast
Development of hexadecyloxypro ...... side/nucleotide-resistant HIV.
@en
type
label
Development of hexadecyloxypro ...... side/nucleotide-resistant HIV.
@ast
Development of hexadecyloxypro ...... side/nucleotide-resistant HIV.
@en
prefLabel
Development of hexadecyloxypro ...... side/nucleotide-resistant HIV.
@ast
Development of hexadecyloxypro ...... side/nucleotide-resistant HIV.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Development of hexadecyloxypro ...... side/nucleotide-resistant HIV.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932